Sumithira Vasu

1.4k total citations
49 papers, 700 citations indexed

About

Sumithira Vasu is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Sumithira Vasu has authored 49 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 23 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Sumithira Vasu's work include Acute Myeloid Leukemia Research (19 papers), Immune Cell Function and Interaction (17 papers) and CAR-T cell therapy research (11 papers). Sumithira Vasu is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Immune Cell Function and Interaction (17 papers) and CAR-T cell therapy research (11 papers). Sumithira Vasu collaborates with scholars based in United States, India and Germany. Sumithira Vasu's co-authors include Spero R. Cataland, Camila Masias, William Blum, Steven M. Devine, John C. Byrd, Michael A. Caligiuri, Rebecca B. Klisovic, Bhavana Bhatnagar, Ramiro Garzon and Jianhua Yu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Sumithira Vasu

46 papers receiving 695 citations

Peers

Sumithira Vasu
Mónica Cabrero Spain
Takamasa Katagiri Japan
Laura Tabellini United States
Maria Spyropoulou‐Vlachou Greece
Johann Hermann Germany
Salman Fazal United States
Alexandra Croockewit Netherlands
Xiao‐Su Zhao China
MV Mateos Spain
Tsuyoshi Takahashi Japan
Mónica Cabrero Spain
Sumithira Vasu
Citations per year, relative to Sumithira Vasu Sumithira Vasu (= 1×) peers Mónica Cabrero

Countries citing papers authored by Sumithira Vasu

Since Specialization
Citations

This map shows the geographic impact of Sumithira Vasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumithira Vasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumithira Vasu more than expected).

Fields of papers citing papers by Sumithira Vasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumithira Vasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumithira Vasu. The network helps show where Sumithira Vasu may publish in the future.

Co-authorship network of co-authors of Sumithira Vasu

This figure shows the co-authorship network connecting the top 25 collaborators of Sumithira Vasu. A scholar is included among the top collaborators of Sumithira Vasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumithira Vasu. Sumithira Vasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wall, Sarah, Sam Penza, Kevin K.W. Ho, et al.. (2025). Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd. Transplantation and Cellular Therapy. 31(2). S82–S83.
2.
3.
Zhao, Qiuhong, Evandro D. Bezerra, Hannah Choe, et al.. (2025). Oral Azacitidine Use after Stem Cell Transplantation for Myeloid Malignancies: A Single Center Experience. Transplantation and Cellular Therapy. 31(2). S429–S430.
4.
Wall, Sarah, Sumithira Vasu, Sam Penza, et al.. (2024). Real-World Clinical Outcomes of Severe, Treatment-Refractory Chronic Gvhd Patients Treated with Axatilimab Combination Therapies. Blood. 144(Supplement 1). 7362–7362. 1 indexed citations
5.
6.
Vasu, Sumithira, Nelli Bejanyan, Steven M. Devine, et al.. (2021). BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM). Transplantation and Cellular Therapy. 27(3). S430–S431. 2 indexed citations
7.
Vasu, Sumithira, Jessica K. Altman, Geoffrey L. Uy, et al.. (2021). A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia. Haematologica. 107(3). 770–773. 7 indexed citations
8.
Mani, Rajeswaran, Xiaokui Mo, John C. Byrd, et al.. (2020). Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia. Cytotherapy. 22(7). 369–376. 14 indexed citations
9.
Kent, Andrew, Sumithira Vasu, Steven M. Devine, et al.. (2020). Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse. Blood Advances. 4(13). 3102–3108. 16 indexed citations
10.
Mani, Rajeswaran, Bhavani Gopalakrishnan, Xiaokui Mo, et al.. (2018). The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors. Haematologica. 103(8). 1288–1297. 33 indexed citations
11.
Mani, Rajeswaran, Xiaokui Mo, Pearlly S. Yan, et al.. (2017). OSU-2S, a Novel PKC Activator, Mediates PKC Dependent Cell Death, Differentiation and Cell Cycle Arrest in Acute Myeloid Leukemia. Blood. 130. 1247–1247. 1 indexed citations
12.
McMichael, Elizabeth L., Brenda F. Reader, Huiqing Fang, et al.. (2016). Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. Journal of Biological Chemistry. 291(49). 25656–25666. 14 indexed citations
13.
Walker, Alison R., Hongyan Wang, Katherine Walsh, et al.. (2016). Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma. 57(9). 2100–2108. 37 indexed citations
14.
15.
Vasu, Sumithira, Susan Geyer, Jeffery J. Auletta, et al.. (2015). Granulocyte Colony-Stimulating Factor–Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(4). 658–668. 16 indexed citations
16.
Pantin, Jeremy, Xin Tian, Nancy L. Geller, et al.. (2014). Long-Term Outcome of Fludarabine-Based Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Debilitating Paroxysmal Nocturnal Hemoglobinuria. Biology of Blood and Marrow Transplantation. 20(9). 1435–1439. 15 indexed citations
17.
He, Shun, Jianhong Chu, Lai‐Chu Wu, et al.. (2013). MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood. 121(23). 4663–4671. 68 indexed citations
18.
Vasu, Sumithira & William Blum. (2013). Emerging immunotherapies in older adults with acute myeloid leukemia. Current Opinion in Hematology. 20(2). 107–114. 6 indexed citations
19.
He, Shun, Jianhong Chu, Sumithira Vasu, et al.. (2013). FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome. Biology of Blood and Marrow Transplantation. 20(3). 309–313. 15 indexed citations
20.
Vasu, Sumithira & Michael A. Caligiuri. (2011). Targeted immunotherapy for acute myeloid leukemia. Best Practice & Research Clinical Haematology. 24(4). 533–540. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Cabrero Breakdown of academic impact, for papers by Takamasa Katagiri Breakdown of academic impact, for papers by Laura Tabellini Breakdown of academic impact, for papers by Maria Spyropoulou‐Vlachou Breakdown of academic impact, for papers by Johann Hermann Breakdown of academic impact, for papers by Salman Fazal Breakdown of academic impact, for papers by Alexandra Croockewit Breakdown of academic impact, for papers by Xiao‐Su Zhao Breakdown of academic impact, for papers by MV Mateos Breakdown of academic impact, for papers by Tsuyoshi Takahashi
Rankless by CCL
2026